Literature DB >> 2824680

Analysis of the IgM and IgG antibody response against herpes simplex virus type 1 (HSV-1) structural and nonstructural proteins.

J E Kühn1, G Dunkler, K Munk, R W Braun.   

Abstract

In the present study the reactivity of IgG and IgM antibodies against HSV-1 structural and nonstructural proteins was analyzed by Western blot analysis (WBA) and radioimmunoprecipitation followed by polyacrylamide gel electrophoresis (RIPA-PAGE). It was demonstrated that IgM and IgG antibodies were directed against viral immediate-early, early, and late proteins. Following acute primary HSV infection, the early IgM antibody response in general was found to be directed against nonglycosylated structural proteins, viral early and immediate-early polypeptides. IgM antibodies against viral glycoproteins were found inconsistently. IgG antibodies against viral glycoproteins and other structural proteins with an apparent molecular weight of 56 kD, 45 kD, and 39 kD could be detected early in infection. Viral early and immediate-early proteins were poorly recognized by IgG antibodies in acute primary infections. In recurrent HSV infections, IgM antibodies revealed a less complex reaction with viral polypeptides. Thus, such IgM antibodies reacted predominantly with viral nonglycosylated structural proteins. In contrast, IgG antibodies from patients with recurrent infections strongly recognized viral structural, early, and immediate-early proteins. In seropositive individuals without obvious symptoms of acute infection, the most prominent antibody response was directed against gB and gD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824680     DOI: 10.1002/jmv.1890230206

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.

Authors:  H J Geerligs; M Feijlbrief; M Bolk; C A Bos; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic active hepatitis.

Authors:  R Abraham; H W Doerr; W Braun; M Stemler; H Will; G Hess; C H Schröder
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections.

Authors:  J Hess; M Stemler; H Will; C H Schröder; J Kühn; R Braun
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

5.  Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface.

Authors:  J E Kühn; M D Kramer; W Willenbacher; U Wieland; E U Lorentzen; R W Braun
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.

Authors:  J E Kühn; K Klaffke; K Munk; R W Braun
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera.

Authors:  U Wieland; J E Kühn; C Jassoy; H Rübsamen-Waigmann; V Wolber; R W Braun
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

8.  Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Authors:  R Burioni; R A Williamson; P P Sanna; F E Bloom; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Homology of the HSV-2 "a-sequence" to cellular sequences.

Authors:  E Kohler; J Kühn; K Munk; R Braun
Journal:  Virus Genes       Date:  1988-03       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.